These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8300056)

  • 1. Growth hormone and insulin-like growth factors as anabolic therapies for osteoporosis.
    Eriksen EF; Kassem M; Brixen K
    Horm Res; 1993; 40(1-3):95-8. PubMed ID: 8300056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of osteoporosis: role of bone-forming agents.
    Reginster JY; Halkin V; Henrotin Y; Gosset C
    Osteoporos Int; 1999; 9 Suppl 2():S91-6. PubMed ID: 10525731
    [No Abstract]   [Full Text] [Related]  

  • 3. Growth hormone (GH) and adult bone remodeling: the potential use of GH in treatment of osteoporosis.
    Brixen K; Kassem M; Eriksen EF; Nielsen HK; Flyvbjerg A; Mosekilde L
    J Pediatr Endocrinol; 1993; 6(1):65-71. PubMed ID: 8374692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone metabolism in relation to alterations in systemic growth hormone.
    Ueland T
    Growth Horm IGF Res; 2004 Dec; 14(6):404-17. PubMed ID: 15519248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoporosis and the growth hormone-insulin-like growth factor axis.
    Geusens PP; Boonen S
    Horm Res; 2002; 58 Suppl 3():49-55. PubMed ID: 12435898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anabolic therapies.
    Marcus R
    Clin Lab Med; 2000 Sep; 20(3):623-37, viii. PubMed ID: 10986625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone (GH) treatment of GH-deficient children increases serum levels of insulin-like growth factors (IGFs), IGF-binding protein-3 and -5, and bone alkaline phosphatase isoenzyme.
    Ono T; Kanzaki S; Seino Y; Baylink DJ; Mohan S
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2111-6. PubMed ID: 8964836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women.
    Murphy MG; Weiss S; McClung M; Schnitzer T; Cerchio K; Connor J; Krupa D; Gertz BJ;
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1116-25. PubMed ID: 11238495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bone and hormones. Effects of growth hormone on bone tissue in adults].
    Chapurlat RD; Delmas PD
    Presse Med; 1999 Mar; 28(10):559-62. PubMed ID: 10209550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human growth hormone as potential therapy for osteoporosis.
    Marcus R
    Baillieres Clin Endocrinol Metab; 1998 Jul; 12(2):251-60. PubMed ID: 10083895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
    Kassem M
    APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of exercise training on bone remodeling, insulin-like growth factors, and bone mineral density in postmenopausal women with and without hormone replacement therapy.
    Milliken LA; Going SB; Houtkooper LB; Flint-Wagner HG; Figueroa A; Metcalfe LL; Blew RM; Sharp SC; Lohman TG
    Calcif Tissue Int; 2003 Apr; 72(4):478-84. PubMed ID: 12574871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone and the insulin-like growth factor system in myogenesis.
    Florini JR; Ewton DZ; Coolican SA
    Endocr Rev; 1996 Oct; 17(5):481-517. PubMed ID: 8897022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of growth hormone administration on bone mineral metabolism, PTH sensitivity and PTH secretory rhythm in postmenopausal women with established osteoporosis.
    Joseph F; Ahmad AM; Ul-Haq M; Durham BH; Whittingham P; Fraser WD; Vora JP
    J Bone Miner Res; 2008 May; 23(5):721-9. PubMed ID: 18052753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal osteoclastic and osteoblastic responses to exogenous growth hormone in patients with postmenopausal spinal osteoporosis.
    Kassem M; Brixen K; Blum WF; Mosekilde L; Eriksen EF
    J Bone Miner Res; 1994 Sep; 9(9):1365-70. PubMed ID: 7817819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone (replacement) therapy in adults: bone and calcium metabolism.
    van der Veen EA; Netelenbos JC
    Horm Res; 1990; 33 Suppl 4():65-8. PubMed ID: 2245971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodeling.
    Riggs BL; Parfitt AM
    J Bone Miner Res; 2005 Feb; 20(2):177-84. PubMed ID: 15647810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of growth hormone and insulin-like growth factor I in men with idiopathic osteoporosis.
    Johansson AG; Lindh E; Blum WF; Kollerup G; Sørensen OH; Ljunghall S
    J Clin Endocrinol Metab; 1996 Jan; 81(1):44-8. PubMed ID: 8550792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone increases bone mineral content in postmenopausal osteoporosis: a randomized placebo-controlled trial.
    Landin-Wilhelmsen K; Nilsson A; Bosaeus I; Bengtsson BA
    J Bone Miner Res; 2003 Mar; 18(3):393-405. PubMed ID: 12619921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New anabolic agents in the treatment of osteoporosis.
    Hough S
    S Afr Med J; 2003 Oct; 93(10):754-6. PubMed ID: 14652963
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.